Modafinil vs Noopept: Complete 2026 Comparison
Side-by-side comparison of Modafinil and Noopept: mechanism, common use cases, dosing protocols from named experts, vendor availability, and expert opinion. Both are framed as research compounds.
TL;DR Table
| Factor | Modafinil | Noopept |
|---|---|---|
| Class | PHARMACEUTICAL | NOOTROPIC |
| Aliases | ["modafanyl", "medafanyl"] | ["nopeps"] |
| Mechanism | n/a | n/a |
| What it's researched for | Wakefulness-promoting DAT inhibitor; increases synaptic dopamine. | Racetam-like dipeptide nootropic with mild dopaminergic action. |
| Dosing mentions tracked | 10 | 4 |
| Vendor recs tracked | 0 | 0 |
| PubMed papers | 8 | 8 |
Mechanism Comparison
What Each is Researched For
Modafinil research areas
Wakefulness-promoting DAT inhibitor; increases synaptic dopamine.
Noopept research areas
Racetam-like dipeptide nootropic with mild dopaminergic action.
Dosing Mention Comparison
Modafinil dosing
- Steve: 50 mg per day (Steve's prior protocol, discontinued due to headache) (00:13:29)
- Vigorous Steve: Previously used 50 mg per day; caused headaches with continued use (00:13:29)
- Steve: 50 mg per day (no longer tolerated) (00:13:29)
- Vigorous Steve: 50 mg per day (his old dose, no longer tolerates); medical dose is 10 mg, he tried 2.5 mg OK, 5 mg too much (00:13:46)
- Steve: Start 25 mg/day, escalate to 50 mg/day (sweet spot), can go up to 75-200 mg; Steve ran 50 mg/day for multiple years (00:25:01)
Noopept dosing
- host: Users report taking 10 mg (up to 20 mg) orally, 30 to 60 minutes before sparring sessions or matches. Some report starting with lower... (00:09:04)
- Steve: 10 mg twice per day, morning and afternoon (00:15:15)
- Steve: 2-3 servings daily, stacked with alpha-GPC + uridine in final serving (00:55:07)
- Speaker 1: Nasal spray Noopept described as short acting for a couple hours; capsules may affect sleep while nasal spray did not for speaker. (01:39:04)
Side Effect Notes
Anecdotal reports for both compounds vary by route, dose, and individual. Neither should be treated as an approved medication. Consult a qualified clinician.
When To Choose Which
Comparison depends on research question, available source quality, and individual risk tolerance. See the full profiles for Modafinil and Noopept for context-specific details.
Can You Stack Them?
Stacking decisions should be evaluated by qualified professionals with attention to dose attribution, source quality, and outcome tracking. This page is a research aggregator and does not recommend stacking protocols.
FAQ
Which has more research?
Modafinil has 8 PubMed citations indexed; Noopept has 8.
Which has more vendor coverage?
Modafinil: 0 tracked vendor recommendations. Noopept: 0.
Are they approved drugs?
Both are framed on this site as research compounds. Verify current FDA status and state-specific rules before any decision.